LY3375880

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LY3375880, covering 2021-04-20 to 2021-04-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY3375880 in Adults With Moderate-to-Severe Atopic Dermatitis [Phase 2]